Search Results - "Campos Tapias, I"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Real World Treatment Patterns of PCSK9 Inhibitors Among Patients with Dyslipidemia in Germany, Spain, and United Kingdom by Tai, M, Shepherd, J, Bailey, H, Hatz, M, Campos Tapias, I, Catterick, D, Worth, G

    Published in Value in health (01-10-2017)
    “…OBJECTIVES: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i), evolocumab and alirocumab, were recently approved as adjuncts to maximal…”
    Get full text
    Journal Article
  2. 2

    A retrospective chart review study describing metastatic melanoma patients profile and treatment patterns in Spain by Márquez-Rodas, I., Arance, A., Berrocal, A., Larios, C. L., Curto-García, J., Campos-Tapias, I. X., Blanca, A. B., Martin-Algarra, S.

    Published in Clinical & translational oncology (01-12-2019)
    “…Purpose To describe patient characteristics by disease stage, resectability status and current treatment management after first diagnosis of IIIB to IV1c…”
    Get full text
    Journal Article
  3. 3

    Resource utilization and costs associated with achieved LDL-C levels in patients following a myocardial infarction treated with lipid-lowering therapies in Spain by Escobar Cervantes, C, Campos Tapias, I, Sorio Vilela, F, Lozano, J, Kahangire, D.A, Sicras-Mainar, A

    Published in European heart journal (01-11-2020)
    “…Abstract Background/Introduction Reduction in low-density lipoprotein cholesterol (LDL-C) significantly reduces cardiovascular (CV) risk, especially in…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11